UCLA Addictions Laboratory
Welcome,         Profile    Billing    Logout  
 25 Trials 
8 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Shoptaw, Steven
NCT05017272: Technology for MAT in Primary Care - Phase 2

Enrolling by invitation
N/A
200
US
Opioid Addiction Recovery Support Software Platform, OARS
Q2i, LLC, University of California, Los Angeles, National Institute on Drug Abuse (NIDA)
Opioid-use Disorder
05/23
08/23
Li, Gang
TRAILBLAZER-ALZ 5, NCT05508789: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease

Recruiting
3
1500
Europe, RoW
Donanemab, (LY3002813), Placebo
Eli Lilly and Company
Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders
04/27
04/27
PM8002-A001, NCT05918445: PM8002 in the Treatment of Patients With Advanced Solid Tumors

Recruiting
1/2
380
RoW
PM8002
Biotheus Inc.
Malignant Neoplasm
11/25
11/25
NCT05755776: The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment

Recruiting
N/A
204
RoW
TMF, Heng Mu
The Second Affiliated Hospital of Chongqing Medical University, Jiangsu Hansoh Pharmaceutical Co., Ltd.
Chronic Hepatitis B
12/24
12/24
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System

Not yet recruiting
N/A
2150
RoW
Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Heart Disease
01/26
01/28
Ray, Lara
NCT03594435: Ibudilast for the Treatment of Alcohol Use Disorder

Completed
2
102
US
Ibudilast, Pinatos, MN-166, Placebo oral capsule, Sugar Pill
University of California, Los Angeles, National Institute on Alcohol Abuse and Alcoholism (NIAAA), MediciNova
Alcohol Use Disorder
04/23
04/23
AFA-281-304, NCT06710431: A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder

Not yet recruiting
2
36
US
AFA-281
Afasci Inc
Alcohol Abuse, Alcohol Abuse/addiction, Anxiety, Pain Threshold, Depression Disorders, Sleep Disorder
06/27
12/27
Jenkins, Jessica
NCT04248283: Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

Recruiting
N/A
167
US
Adjustable Continence Therapy for Women (ACT)
Uromedica
Urinary Incontinence, Urinary Incontinence,Stress
09/25
12/25
Levanthal, Adam
No trials found
Lunny, Katy
No trials found

Download Options